MSD investment confirms thriving biopharmaceutical hub
European Pharmaceutical Review | June 08, 2017
BioPharmaChem Ireland, the Ibec group that represents business in the sector, said the announcement of MSD to invest €280 million in Ireland over the next three years bolsters the country’s status as a thriving hub for the biopharmaceutical sector.